Article
Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response.
The American journal of gastroenterology - 1 Oct 2010
Fernández-Rodríguez Conrado M, Alonso Sonia, Martinez Stella M, Forns Xavier, Sanchez-Tapias Jose M, Rincón Diego, Rodriguez-Caravaca Gil, Bárcena Rafael, Serra Miguel A, Romero-Gómez Manuel, Fernandez Inmaculada, Garcia-Samaniego Javier, Fuente Javier, Solá Ricard, Moreno-Otero Ricardo, Planas Ramón
Abstract excerpt
OBJECTIVES: Patients with hepatitis C virus (HCV) cirrhosis are difficult to treat and have a high risk of liver decompensation or hepatocellular carcinoma. We sought to identify factors that could predict treatment response. METHODS: Collaborating centers (n=26) provided data for patients (n=568) with HCV cirrhosis undergoing treatment with peginterferon-α plus ribavirin (RBV). Univariate and multivariate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.